Michael W. Marcus
Astellas Pharma (Netherlands)(NL)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, RNA modifications and cancer, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Global Cancer Incidence and Screening
Most-Cited Works
- → Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes(2017)774 cited
- → Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study(2017)660 cited
- → Myopia as a Risk Factor for Open-Angle Glaucoma: A Systematic Review and Meta-Analysis(2011)655 cited
- → Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis(2020)148 cited
- → Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium(2015)87 cited
- → Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort Study(2012)84 cited
- → LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence(2015)81 cited
- → Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk(2018)80 cited
- → Welding and Lung Cancer in a Pooled Analysis of Case-Control Studies(2013)62 cited
- → Aurora B expression modulates paclitaxel response in non-small cell lung cancer(2017)59 cited